FDA Eyeing Other PD-1/L1 Drugs With Clinical Hold On Keytruda Myeloma Trials

 
• By Michael Cipriano
Yellow road sign with a blue sky and white clouds: clinical trial
US FDA has detailed the data that led to a clinical hold on Keytruda multiple myeloma trials

More from Drug Safety

More from Pink Sheet